Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
8.30
+0.26 (3.23%)
At close: Aug 13, 2025, 4:00 PM
8.23
-0.07 (-0.84%)
Pre-market: Aug 14, 2025, 8:53 AM EDT
Capricor Therapeutics Stock Forecast
Stock Price Forecast
According to 8 professional analysts, the 12-month price target for Capricor Therapeutics stock ranges from a low of $12 to a high of $35. The average analyst price target of $24.75 forecasts a 198.19% increase in the stock price over the next year.
Price Target: $24.75 (+198.19%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Jul 14, 2025.
Analyst Ratings
The average analyst rating for Capricor Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth Capital | Roth Capital | Strong Buy Maintains $31 → $12 | Strong Buy | Maintains | $31 → $12 | +44.58% | Jul 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $77 → $24 | Strong Buy | Maintains | $77 → $24 | +189.16% | Jul 11, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $21 | Strong Buy | Initiates | $21 | +153.01% | Jun 26, 2025 |
| Jones Trading | Jones Trading | Strong Buy Maintains $40 → $29 | Strong Buy | Maintains | $40 → $29 | +249.40% | Jun 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $77 | Strong Buy | Reiterates | $77 | +827.71% | Jun 24, 2025 |
Financial Forecast
Revenue This Year
25.89M
from 22.27M
Increased by 16.24%
Revenue Next Year
110.83M
from 25.89M
Increased by 328.11%
EPS This Year
-0.97
from -1.15
EPS Next Year
-0.31
from -0.97
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 243.6M | 243.6M | 227.5M | ||
| Avg | 25.9M | 110.8M | 108.2M | ||
| Low | n/a | 9.8M | 48.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 993.8% | 841.0% | 105.3% | ||
| Avg | 16.2% | 328.1% | -2.4% | ||
| Low | - | -62.1% | -56.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.80 | 1.44 | 1.74 | ||
| Avg | -0.97 | -0.31 | 0.38 | ||
| Low | -2.07 | -1.35 | -0.73 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.